☰

Sang Taek Jung - Publications

Affiliations: 
1993-1999 Chemical Technology Seoul National University, Seoul, South Korea 
 2004- Chemical Engineering University of Texas at Austin, Austin, Texas, U.S.A. 
 2011-2012 Chemistry and Chemical Engineering California Institute of Technology, Pasadena, CA 
 2012-2019 Bio and Nano Chemistry Kookmin University 
 2019- Department of Biomedical Sciences Korea University, Seoul, South Korea 
Website:
https://apel.korea.ac.kr/
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Lee W, Lee SM, Jung ST. Unlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer Treatments. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. PMID 37486566 DOI: 10.1007/s40259-023-00618-1  0.44
2023 Kim WS, Chae HD, Jung I, Lee WK, Lee WJ, Lee J, Gong Y, Lee D, Kim BW, Kim JK, Hwang J, Kweon DH, Jung ST, Na JH. Isolation and characterization of single domain antibodies from banded houndshark (Triakis scyllium) targeting SARS-CoV-2 spike RBD protein. Fish & Shellfish Immunology. 108807. PMID 37169112 DOI: 10.1016/j.fsi.2023.108807  0.774
2023 Ha JY, Chun KJ, Ko S, Lee HW, Hwang OK, Lim CS, Ha K, Ko BJ, Jung ST. Glycan-Controlled Human PD-1 Variants Displaying Broad-Spectrum High Binding to PD-1 Ligands Potentiate T Cell. Molecular Pharmaceutics. PMID 36897183 DOI: 10.1021/acs.molpharmaceut.3c00003  0.386
2022 Ko S, Ju MS, Ahn HM, Na JH, Ko WH, Jo M, Kyung M, Lim CS, Ko BJ, Lee WK, Kim YJ, Jung ST. Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular Pharmaceutics. PMID 36563318 DOI: 10.1021/acs.molpharmaceut.2c00923  0.776
2022 Kim WS, Kim JH, Lee J, Ka SY, Chae HD, Jung I, Jung ST, Na JH. Functional Expression of the Recombinant Spike Receptor Binding Domain of SARS-CoV-2 Omicron in the Periplasm of . Bioengineering (Basel, Switzerland). 9. PMID 36354581 DOI: 10.3390/bioengineering9110670  0.748
2022 Ko S, Park S, Sohn MH, Jo M, Ko BJ, Na JH, Yoo H, Jeong AL, Ha K, Woo JR, Lim C, Shin JH, Lee D, Choi SY, Jung ST. An Fc variant with two mutations confers prolonged serum half-life and enhanced effector functions on IgG antibodies. Experimental & Molecular Medicine. PMID 36319752 DOI: 10.1038/s12276-022-00870-5  0.784
2021 Ju MS, Ahn HM, Han SG, Ko S, Na JH, Jo M, Lim CS, Ko BJ, Yu YG, Lee WK, Kim YJ, Jung ST. A human antibody against human endothelin receptor type A that exhibits antitumor potency. Experimental & Molecular Medicine. PMID 34588605 DOI: 10.1038/s12276-021-00678-9  0.767
2021 Ko S, Jo M, Jung ST. Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. PMID 33608823 DOI: 10.1007/s40259-021-00471-0  0.442
2020 Ju MS, Jung ST. Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies. International Journal of Molecular Sciences. 21. PMID 33153215 DOI: 10.3390/ijms21218240  0.421
2020 Ko S, Jeon H, Yoon S, Kyung M, Yun H, Na JH, Jung ST. Discovery of Novel Pseudomonas putida Flavin-Binding Fluorescent Protein Variants with Significantly Improved Quantum Yield. Journal of Agricultural and Food Chemistry. PMID 32367716 DOI: 10.1021/acs.jafc.0c00121  0.686
2020 Lee J, Der BS, Karamitros CS, Li W, Marshall NM, Lungu OI, Miklos AE, Xu J, Kang TH, Lee CH, Tan B, Hughes RA, Jung ST, Ippolito GC, Gray JJ, et al. Computer-based Engineering of Thermostabilized Antibody Fragments. Aiche Journal. American Institute of Chemical Engineers. 66. PMID 32336757 DOI: 10.1002/Aic.16864  0.769
2020 Kang TH, Jung ST. Reprogramming the Constant Region of Immunoglobulin G Subclasses for Enhanced Therapeutic Potency against Cancer. Biomolecules. 10. PMID 32121592 DOI: 10.3390/biom10030382  0.764
2019 Kang TH, Jung ST. Boosting therapeutic potency of antibodies by taming Fc domain functions. Experimental & Molecular Medicine. 51: 138. PMID 31735912 DOI: 10.1038/s12276-019-0345-9  0.78
2019 Ko S, Hwang B, Na JH, Lee J, Jung ST. Engineered Arabidopsis blue light receptor LOV domain variants with improved quantum yield, brightness, and thermostability. Journal of Agricultural and Food Chemistry. PMID 31581772 DOI: 10.1021/acs.jafc.9b05473  0.689
2019 Yoon HW, Jo M, Ko S, Kwon HS, Lim CS, Ko BJ, Lee JC, Jung ST. Optimal combination of beneficial mutations for improved ADCC effector function of aglycosylated antibodies. Molecular Immunology. 114: 62-71. PMID 31336250 DOI: 10.1016/j.molimm.2019.07.007  0.51
2019 Lee BS, Lee Y, Park J, Jeong BS, Jo M, Jung ST, Yoo TH. Construction of an immunotoxin via site-specific conjugation of anti-Her2 IgG and engineered exotoxin A. Journal of Biological Engineering. 13: 56. PMID 31285754 DOI: 10.1186/s13036-019-0188-x  0.457
2018 Jo M, Hwang B, Yoon HW, Jung ST. Escherichia coli inner membrane display system for high-throughput screening of dimeric proteins. Biotechnology and Bioengineering. PMID 30171695 DOI: 10.1002/bit.26826  0.317
2017 Jo M, Kwon HS, Lee KH, Lee JC, Jung ST. Engineered aglycosylated full-length IgG Fc variants exhibiting improved FcγRIIIa binding and tumor cell clearance. Mabs. 1-12. PMID 29173039 DOI: 10.1080/19420862.2017.1402995  0.511
2017 Han SG, Ko S, Lee WK, Jung ST, Yu YG. Determination of the endothelin-1 recognition sites of endothelin receptor type A by the directed-degeneration method. Scientific Reports. 7: 7577. PMID 28790412 DOI: 10.1038/s41598-017-08096-6  0.656
2017 Chauhan S, Hou CY, Jung ST, Kang TJ. Detection and purification of backbone-cyclized proteins using a bacterially expressed anti-myc-tag single chain antibody. Analytical Biochemistry. PMID 28600127 DOI: 10.1016/j.ab.2017.06.003  0.336
2016 Park HI, Yoon HW, Jung ST. The Highly Evolvable Antibody Fc Domain. Trends in Biotechnology. PMID 27173171 DOI: 10.1016/j.tibtech.2016.04.005  0.492
2016 Jo M, Jung ST. Engineering therapeutic antibodies targeting G-protein-coupled receptors. Experimental & Molecular Medicine. 48: e207. PMID 26846450 DOI: 10.1038/emm.2015.105  0.355
2015 Ju MS, Na JH, Yu YG, Kim JY, Jeong C, Jung ST. Structural consequences of aglycosylated IgG Fc variants evolved for FcγRI binding. Molecular Immunology. PMID 26153451 DOI: 10.1016/j.molimm.2015.06.020  0.779
2014 Ju MS, Jung ST. Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics. Current Opinion in Biotechnology. 30: 128-39. PMID 25035939 DOI: 10.1016/j.copbio.2014.06.013  0.505
2013 Wine Y, Boutz DR, Lavinder JJ, Miklos AE, Hughes RA, Hoi KH, Jung ST, Horton AP, Murrin EM, Ellington AD, Marcotte EM, Georgiou G. Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response. Proceedings of the National Academy of Sciences of the United States of America. 110: 2993-8. PMID 23382245 DOI: 10.1073/Pnas.1213737110  0.555
2013 Jung ST, Kelton W, Kang TH, Ng DT, Andersen JT, Sandlie I, Sarkar CA, Georgiou G. Effective phagocytosis of low Her2 tumor cell lines with engineered, aglycosylated IgG displaying high FcγRIIa affinity and selectivity. Acs Chemical Biology. 8: 368-75. PMID 23030766 DOI: 10.1021/Cb300455F  0.805
2012 Borrok MJ, Jung ST, Kang TH, Monzingo AF, Georgiou G. Revisiting the role of glycosylation in the structure of human IgG Fc. Acs Chemical Biology. 7: 1596-602. PMID 22747430 DOI: 10.1021/Cb300130K  0.769
2012 Brustad EM, Lelyveld VS, Snow CD, Crook N, Jung ST, Martinez FM, Scholl TJ, Jasanoff A, Arnold FH. Structure-guided directed evolution of highly selective p450-based magnetic resonance imaging sensors for dopamine and serotonin. Journal of Molecular Biology. 422: 245-62. PMID 22659321 DOI: 10.1016/J.Jmb.2012.05.029  0.69
2011 Jung ST, Kang TH, Kelton W, Georgiou G. Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy. Current Opinion in Biotechnology. 22: 858-67. PMID 21420850 DOI: 10.1016/J.Copbio.2011.03.002  0.789
2011 Jung ST, Lauchli R, Arnold FH. Cytochrome P450: taming a wild type enzyme. Current Opinion in Biotechnology. 22: 809-17. PMID 21411308 DOI: 10.1016/J.Copbio.2011.02.008  0.41
2010 Qiu JK, Jung ST, Georgiou G, Hang HY. Enrichment of Escherichia coli spheroplasts displaying scFv antibodies specific for antigens expressed on the human cell surface. Applied Microbiology and Biotechnology. 88: 1385-91. PMID 20878322 DOI: 10.1007/S00253-010-2861-3  0.698
2010 Jung ST, Kang TH, Georgiou G. Efficient expression and purification of human aglycosylated Fcgamma receptors in Escherichia coli. Biotechnology and Bioengineering. 107: 21-30. PMID 20506277 DOI: 10.1002/Bit.22785  0.789
2010 Jung ST, Reddy ST, Kang TH, Borrok MJ, Sandlie I, Tucker PW, Georgiou G. Aglycosylated IgG variants expressed in bacteria that selectively bind FcgammaRI potentiate tumor cell killing by monocyte-dendritic cells. Proceedings of the National Academy of Sciences of the United States of America. 107: 604-9. PMID 20080725 DOI: 10.1073/Pnas.0908590107  0.798
2007 Jung ST, Jeong KJ, Iverson BL, Georgiou G. Binding and enrichment of Escherichia coli spheroplasts expressing inner membrane tethered scFv antibodies on surface immobilized antigens. Biotechnology and Bioengineering. 98: 39-47. PMID 17657772 DOI: 10.1002/Bit.21405  0.591
Show low-probability matches.